Equities

XtalPi Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

XtalPi Holdings Ltd

Actions
  • Price (HKD)11.25
  • Today's Change0.04 / 0.36%
  • Shares traded15.02m
  • 1 Year change+70.20%
  • Beta--
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

XtalPi Holdings Ltd is a holding company primarily engaged in the provision of drug and material science research and development solutions and services in the pharmaceutical and material science industries. The Company mainly operates two businesses. Drug discovery solutions primarily encompass the development of early-stage lead compounds and investigational new drugs, providing research support for clinical trial initiation. Intelligent robotics solutions primarily include solid-state research and development services and automated chemical synthesis services. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)770.29m
  • Net income in HKD-222.64m
  • Incorporated2017
  • Employees1.05k
  • Location
    XtalPi Holdings Ltd3/F, Second Phase of the InternationalNo. 2 Hongliu Road, Futian districtSHENZHEN ChinaCHN
  • Websitehttps://www.xtalpi.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.